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The recent identification of fluid flow or shear stress as a potent stimulus for biliary epithelial cell ATP release adds an important link to the P2-signaling pathway (44) . The mechanical effect of fluid flow on the cholangiocyte apical membrane, by stimulating ATP release, increases [Ca 2ϩ ] i and activates non-CFTR Cl Ϫ channels through a process requiring agonist binding to apical P2 receptors. Thus mechanosensitive ATP release and P2-signaling may complement, or even surpass, secretin-mediated cAMP-dependent secretion through CFTR. In fact, recent evidence suggests that a major function of biliary CFTR is to regulate ATP release from an intracellular site into the duct lumen and that ATP release per se represents a final common pathway transducing secretin and other secretagogue effects (27) .
Although cholangiocytes express a repertoire of P2 receptors, including both P2X and P2Y, their relative contributions are unknown. P2X receptors are ligand-gated cation channels, where ATP binding leads to opening of a calcium-permeable pore and calcium influx from extracellular sites. In contrast, P2Y receptors are members of the superfamily of G proteincoupled receptors often coupled to phospholipase C and generation of inositol 1,4,5-triphosphate (IP3). In biliary epithelial cells, the pathways linking receptor binding to Cl Ϫ efflux are unknown. Consequently, the purpose of the present studies was to identify the intracellular pathways linking P2 receptor binding to increases in intracellular [Ca 2ϩ ] i and Cl Ϫ channel activation. The findings support a dominant role for P2Y receptors leading to sequential activation of PLC generation, IP3 receptor stimulation, release of Ca 2ϩ from intracellular stores, and Cl Ϫ channel activation. Together these elements constitute a P2-linked signaling complex in the apical domain of cholangiocytes regulating biliary secretion. Importantly, the pathway is independent of, and of greater magnitude than, CFTR-mediated secretion. Thus the apical P2Y-IP3 receptor signaling complex represents an important pathway mediating biliary epithelial cell secretion.
METHODS
Cell models. Studies in isolated cells were performed using Mz-Cha-1 cells and in polarized monolayers were performed utilizing normal rat cholangiocytes (NRC). Mz-Cha-1, originally isolated from human adenocarcinoma of the gallbladder (23) , were passaged at biweekly intervals and maintained in culture at 37°C in a 5% CO 2 incubator in HCO 3 Ϫ containing CMRL-1066 media (GIBCO-BRL, Grand Island, NY) supplemented with 10% heat-inactivated fetal bovine serum, penicillin (100 IU/ml), and streptomycin (100 g/ml). Mz-Cha-1 cells exhibit phenotypic features of differentiated biliary epithelium (4, 23) . When cultured as described, they have been utilized as models for biliary ATP release, purinergic signaling (16) , and Ca 2ϩ -dependent secretion (14, 31, 43) . Since Mz-ChA-1 cells do not form high-resistance monolayers in culture, additional Ussing chamber studies were performed utilizing NRC monolayers isolated from intrahepatic bile ducts (42) . These cells express phenotypic features of differentiated biliary epithelium including receptors, signaling pathways, and ion channels similar to those found in primary cells (32, 35) . Moreover, exposure to ATP is followed by opening of apical membrane Cl Ϫ channels, producing an increase in short-circuit current (I sc), the electrical signature of transepithelial secretion. NRC monolayers were cultured on rat tail collagen slabs as previously described (33, 35) and passaged onto collagen-coated semipermeable (24-mm diameter, 0.4-m pore) Costar Transwell supports (Corning) 7-10 days before all electrophysiological and molecular studies. This protocol permits highly polarized cells, the development of a high transepithelial resistance (R t Ͼ 1,000 ⍀⅐cm 
Measurement of membrane Cl
Ϫ currents. Membrane currents were measured by whole cell and single-channel patch clamp techniques. Cells on a coverslip were mounted in a chamber (volume ϳ400 l) and whole cell currents measured with a standard extracellular solution containing (in mM) 140 NaCl, 4 KCl, 1 CaCl2, 2 MgCl2, 1 KH2PO4, 10 glucose, and 10 HEPES/NaOH (pH ϳ7.40). The standard intracellular (pipette) solution for whole cell recordings contained (in mM) 130 KCl, 10 NaCl, 2 MgCl2, 10 HEPES/KOH, 0.5 CaCl2, 3 MgATP 2Ϫ or NaATP 4Ϫ , and 1 EGTA (pH 7.3), corresponding to a Ca 2ϩ concentration of ϳ100 nM (6) . Patch pipettes were pulled from Corning 7052 glass and had a resistance of 2-5 or 7-10 M⍀ for whole cell and single-channel recordings, respectively. Recordings were made with an Axopatch ID amplifier (Axon Instruments, Foster City, CA) and were filtered at 1-2 kHz and sampled at 4 kHz for storage on a computer and analyzed by using pCLAMP version 10 (Axon Instruments, Burlingame, CA) as previously described (19, 24) . Two voltage protocols were utilized: 1) holding potential Ϫ40 mV, with 200-ms steps to 0 mV and Ϫ80 mV at 10 s intervals (for real-time tracings), and 2) holding potential Ϫ40 mV, with 400-ms steps from Ϫ100 mV to ϩ100 mV in 20 mV increments. Current-voltage (I-V) relations were generated from the "step" protocol. Pipette voltages (Vp) are referred to the bath. In the whole cell configuration, Vp corresponds to the membrane potential, and upward deflections of the current trace indicate outward membrane current. In the cell-attached patch configuration, applied voltages represent ϪVp values. Results are compared with control studies measured on the same day to minimize any effects of day-to-day variability and reported as current density (pA/pF) to normalize for differences in cell size (13) . The average whole cell capacitance for the Mz-Cha-1 cells was 22.6 Ϯ 1.1 pF (mean Ϯ SE). For the majority of single-channel studies standard extracellular buffer (described above) was used for both bath and pipette solutions. For selected studies, a high-K ϩ bath and pipette solution was utilized (changes from standard extracellular buffer: 140 mM KCl, 4 mM NaCl, 5 mM BaCl 2) to hold EKϩ at ϳ0 mV and minimize the effects of the interior negative membrane potential, where E is the equilibrium potential. Average open probability (NP o) was determined from 6-to 10-s recordings and mean open times were determined by using pClamp systems and OriginPro 7.0 software (MicroCal Software, Northampton, MA). The number of channels in each patch (N) was measured by using an all-points amplitude histogram and calculated as the peak current divided by the unitary current. The slope conductance was calculated from currents at positive voltages.
Transepithelial Cl Ϫ secretion. NRC cells were utilized to study the relative contribution of P2 receptors and the pathways involved in extracellular nucleotide-stimulated transepithelial Cl Ϫ secretion. Cells were grown to confluence on collagen-treated polycarbonate filters with a pore size of 0.4 m (Costar, Cambridge, MA) until resistance was Ͼ1,000 ⍀ ⅐ cm 2 (EVOHM; World Precision Instruments, Sarasota, FL) (33) . Cells were mounted in a Trans-24 miniperfusion system for tissue culture cups (Jim's Instrument Manufacturing, Iowa City, IA). All experiments were carried out at 37°C, and basolateral and apical (luminal) sides were bubbled with O2 through air-lift circulators. The standard extracellular buffer solution containing (in mM) 140 NaCl, 4 KCl, 1 KH2PO4, 2 MgCl2, 1 CaCl2, 5 glucose, and 10 HEPES/NaOH (pH 7.3). Transepithelial voltage was clamped to 0 mV and Isc was recorded through agar bridges (3% agar in 1 M KCl) connected to Ag-AgCl electrodes (cartridge electrodes, World Precision Instruments). The Isc represents the net sum of the transepithelial anion and cation fluxes and reflects the level of ion and fluid secretion (35) . Studies included paired, same-day monolayers to minimize any potential effects of day-to-day variability.
Reagents. Thapsigargin was obtained from Calbiochem/EMD Biosciences (La Jolla, CA). The phospholipase C inhibitor U73122, the inactive analog U73343, and the IP3 receptor inhibitor 2-APB were obtained from Calbiochem/EMD Biosciences and from MP Biomedicals (Solon, OH). Since 2-APB can affect gap junction channels in other cell models (3, 22) and, hence, alter cell capacitance during the whole cell patch clamp experiments, capacitance measurements were performed in the presence (21.5 Ϯ 1.2 pF) and absence (22.6 Ϯ 1.1 pF) of the reagent and were determined to be statistically without difference [P ϭ 0.63, not significant (NS)], thus ensuring that 2-APB did not have unanticipated effects on cell capacitance. The cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor, CFTRinh-172, was a kind gift from Dr. Nitin Sonawane and Dr. Alan Verkman (Univ. of California, San Francisco, CA). All other reagents were obtained from Sigma-Aldrich (St. Louis, MO).
Statistics. Results are presented as means Ϯ SE, with n representing the number of culture plates or repetitions for each assay as indicated. Student's paired or unpaired t-test or ANOVA for multiple comparisons was used to assess statistical significance as indicated, and P values Ͻ0.05 were considered to be statistically significant.
RESULTS

Characterization of ATP-stimulated Cl
Ϫ channels. To develop a functional characterization of the Cl Ϫ channel(s) activated by ATP, whole cell patch clamp studies were performed in Mz-Cha-1 cells. Under basal conditions with standard intraand extracellular buffers, I Cl Ϫ was small (Ϫ1.7 Ϯ 0.3 pA/pF, n ϭ 33). Exposure to ATP (50 M) resulted in activation of currents within 2 min (representative trace shown in Fig. 1 ), increasing current density to Ϫ13.6 Ϯ 1.2 pA/pF at Ϫ80 mV (n ϭ 33, P Ͻ 0.001 compared with basal, Fig. 1 ). ATP-stimulated currents exhibited characteristic biophysical features with reversal at 0 mV (E Cl Ϫ ), time-dependent inactivation, and outward rectification as described previously (25) (Fig. 1B ). Currents were sustained for the duration of ATP exposure, followed by gradual return to basal levels within 5-10 min following removal of ATP from the extracellular buffer. ATP-stimulated currents were dependent on intracellular Ca 2ϩ as chelation (2 mM EGTA in pipette) significantly decreased maximum current density to Ϫ0.5 Ϯ 0.2 pA/pF (n ϭ 6, P Ͻ 0.05, Fig. 1, C and D) . Additionally, currents were reversibly inhibited by 5-nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB, 100 M), which decreased maximum current density measured at Ϫ80 mV to Ϫ2.6 Ϯ 1.3 pA/pF (n ϭ 8, Similarly, whole cell patch-clamp measurements of Cl Ϫ currents showed parallel responses. Exposure to UTP (50 M) increased current density from Ϫ1.3 Ϯ 0.4 to Ϫ13.1 Ϯ 2.7 pA/pF (n ϭ 6, P Ͻ 0.01). The UTP-induced currents exhibited identical properties to the ATP-stimulated currents with a reversal potential at 0 mV, time-dependent inactivation at potentials Ͼϩ60 mV, and inhibition by NPPB (100 M) (Ϫ3.7 Ϯ 1.1 pA/pF, n ϭ 5 each, P Ͻ 0.05, Fig. 3C ). In contrast, Bz-ATP (50 M) resulted in current activation in only ϳ47% of cells, and the currents were of lower magnitude (maximum current density measured at Ϫ80 mV of Ϫ8.8 Ϯ 3.6 pA/pF at 10 min, n ϭ 4), more linear, without time-dependent inactivation, and were only partially inhibited by NPPB (Fig.   Fig. 1 . Characterization of whole cell ATPstimulated currents. Exposure to ATP stimulates currents in human Mz-Cha-1 biliary epithelial cells. Whole cell currents were measured during basal conditions and during exposure to ATP (50 M) (METHODS).
A: representative whole cell recording. Currents measured at Ϫ80 mV (E), representing I Cl Ϫ , and at 0 mV (F), representing I K ϩ , are shown. ATP exposure is indicated by the bar. A voltage-step protocol (test potentials between Ϫ100 mV and ϩ100 mV in 20-mV increments) was obtained at aଙ (basal) and bଙ (maximal current response) as indicated. The current-voltage (I-V) plot shown in B was generated from these protocols. B: I-V relationship of whole cell currents during basal (E) and ATP-stimulated (F) conditions. C: representative ATP-stimulated whole cell current tracings measured at Ϫ80 mV in the absence of intracellular Ca 2ϩ (EGTA 2 mM in pipette solution) or presence of Cl Ϫ channel inhibitors. D: cumulative data demonstrating magnitude of ATP-stimulated currents in the presence or absence of the Cl Ϫ channel inhibitors 5-nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB; 100 M), DIDS (100 M), or CFTRinh-172 (5 M) or removal of intracellular Ca 2ϩ (EGTA in pipette). Values represent maximum current density (pA/pF) measured at Ϫ80 mV (n ϭ 5-11 each). *ATP-stimulated currents were significantly inhibited (P Ͻ 0.05 for each). 3D). This pharmacological profile of nucleotide-stimulated increases in [Ca 2ϩ ] i and Cl Ϫ currents, ATP ϭ UTP Ͼ Ͼ Bz-ATP, is consistent with P2Y receptors playing a prominent role in transducing extracellular ATP into secretory responses in biliary epithelial cells, in agreement with molecular data demonstrating that P2Y receptors are abundant in biliary epithelium (11, 35) .
Antagonist profile of ATP-stimulated Ca 2ϩ fluorescence and Cl Ϫ currents. To further characterize the receptors involved in ATP-stimulated signaling, the response to ATP was measured in Mz-Cha-1 cells in the presence or absence of P2 receptor antagonists as summarized in Table 2 . First, compared with control cells (1,101 Ϯ 438 nM, n ϭ 5), both suramin (50 Ϯ 21 nM, n ϭ 7, P Ͻ 0.05) and reactive blue 2 (25 M), a structurally unrelated P2Y inhibitor, (24 Ϯ 7 nM, n ϭ 7, P Ͻ 0.05) significantly inhibited ATP-stimulated [Ca 2ϩ ] i (Fig. 4, A and B) . Conversely, the P2X receptor antagonist brilliant blue G had little effect on ATP-stimulated increases in [Ca 2ϩ ] i (733 Ϯ 79 nM, n ϭ 4, P ϭ NS, Fig. 4C ). Similarly, in separate studies, ATP-stimulated Cl Ϫ currents were inhibited by either suramin (100 M, Ϫ2.2 Ϯ 0.8 pA/pF, n ϭ 6, P Ͻ 0.001) or reactive blue 2 (25 M, Ϫ2.8 Ϯ 0.5 pA/pF, n ϭ 4, P Ͻ 0.001, Fig. 4 , D and E) compared with control cells (Ϫ14.7 Ϯ 1.7 pA/pF, n ϭ 7). However, the P2X receptor antagonist brilliant blue G Ϫ currents that were unaffected by inactive U73343 (Ϫ14.6 Ϯ 3.1 pA/pF, n ϭ 6, Fig. 6, A and D) but completely abolished by either U73122 (Ϫ2.4 Ϯ 0.5 pA/pF, n ϭ 4, P Ͻ 0.01, Fig. 6 , B and D) or 2-APB (Ϫ0.1 Ϯ 0.5 pA/pF, n ϭ 6, P Ͻ 0.01, Fig. 6, C and D) . Continued release from intracellular stores is necessary for continued ATP-stimulated Cl Ϫ currents as addition of 2-APB during maximum current activation also decreased current magnitude significantly (Ϫ3.2 Ϯ 1.2 pA/pF, n ϭ 5, P Ͻ 0.05, data not shown).
Intracellular dialysis with purified IP3 activates membrane Cl Ϫ currents. To confirm the role of IP3 on membrane Cl Ϫ currents, purified IP3 was delivered to the cell interior during whole cell patch clamp. Whole cell currents (measured at Ϫ80 mV) remained small in control cells (Ϫ2.9 Ϯ 0.8 pA/pF, n ϭ 4, Fig. 7 , A and C). In contrast, when IP3 was included in the patch pipette, spontaneous activation of currents was observed as IP3 diffused into the cell interior with a maximum current density measured at Ϫ80 mV of Ϫ9.4 Ϯ 1.2 pA/pF (n ϭ 4, P Ͻ 0.005, Fig. 7A , bottom, and 7C). These currents demonstrated identical characteristics to the ATP-stimulated currents with reversal at 0 mV, outward rectification, and time-dependent inactivation at depolarizing potentials above ϩ60 mV (Fig. 7, A-C) . Single-channel characterization. To characterize the channel types contributing to ATP-stimulated Cl Ϫ currents, unitary currents were measured in the cell-attached configuration. Under basal conditions, few spontaneous openings were evident (Fig. 8) . Exposure to ATP (50 M) activated currents (Fig. 8A) , increasing NP o from 0.04 Ϯ 0.02 to 0.74 Ϯ 0.02 (n ϭ 6, P Ͻ 0.05). Representative amplitude histograms are shown under each tracing, demonstrating the effect of ATP on NP o . In this example, two open levels are apparent. Because a nonselective cation (NSC) conductance could also contribute to currents, additional studies were performed to establish that the ATP-stimulated currents were mediated by Cl Ϫ . First, replacement of the pipette monovalent cations by tetraethylammonium did not affect the magnitude or reversal potential of the ATP-stimulated currents (n ϭ 5, P ϭ NS), thus excluding a contribution from an NSC conductance (Fig. 8B, left) . Second, in the presence of the Cl Ϫ channel blocker NPPB (100 M), NP o of ATP-stimulated currents decreased significantly from 0.60 Ϯ 0.10 to 0.13 Ϯ 0.10 (n ϭ 5, P Ͻ 0.01, Fig. 8B,  right) . Additional studies were performed with a high-K ϩ bath and pipette solution designed to hold E K ϩ at 0 mV and minimize the effects of the interior negative membrane potential (Fig. 8C) . To exclude the possibility that unitary currents under these conditions were carried by K ϩ , Ba 2ϩ was included in both bath and pipette solutions to effectively block K ϩ channels. Under these conditions, ATP induced similar currents with an observed reversal at 0 mV (E Cl Ϫ , Fig. 8, C and D) . Single-channel conductance was calculated at positive potentials and was 17.1 Ϯ 0.1 pS (n ϭ 7, Fig. 8D ). To our knowledge these represent the first single-channel recordings of ATP-stimulated currents in biliary epithelial cells. In summary, exogenous ATP stimulates a 17-pS Cl Ϫ channel dependent on intracellular Ca 2ϩ and distinct from CFTR. Transepithelial Cl Ϫ secretion. NRC form high-resistance monolayers (R t Ͼ 1,000 ⍀ ⅐cm 2 ) and respond to secretory agonists by increasing their apical Cl Ϫ conductance (35) . Addition of 8-(4-chlorophenylthio)-adenosine-3Ј,5-cyclic monophosphate, sodium salt (cpt)-cAMP (500 M) and 3-isobutyl-1-methylxanthine (IBMX; 100 M) to the apical chamber (to activate CFTR) increased I sc from 4.2 Ϯ 2.4 A/cm 2 (n ϭ 8) to 14.7 Ϯ 1.7 A/cm 2 (n ϭ 4, P Ͻ 0.05, Fig. 9, A and B) . Subsequent addition of ATP to the apical chamber further increased the I sc to 30.1 Ϯ 6.4 A/cm 2 (n ϭ 4, P Ͻ 0.05 vs. maximal increase with cAMP-IBMX). In the presence of CFTR inh -172 (5 M), the cpt-cAMP-IBMX-induced ⌬I sc was inhibited (2.1 Ϯ 1.1 A/cm 2 , P Ͻ 0.01 vs. maximal cAMP-IBMX-induced ⌬I sc ), but the ATP-induced I sc was unaffected (28.7 Ϯ 5.8 A/cm 2 , n ϭ 4 each, P ϭ NS vs. maximal ATP-induced ⌬I sc , Fig. 9, A and B) . This important finding demonstrates that ATP stimulates transepithelial Cl Ϫ secretion from NRC monolayers through CFTR-independent pathways. To determine whether the P2Y-IP3 receptor pathway contributes to the ATP-stimulated increase in transepithelial secretion, further individual studies were performed in the presence or absence of the P2Y receptor antagonist suramin (100 M), the PLC inhibitor U73122 (10 M), or the IP3 receptor inhibitor 2-APB (100 M). In control cells, ATP-stimulated a large increase in I sc (21.9 Ϯ 5.4 A/cm 2 , n ϭ 9, Fig. 9, C and D) , which was significantly inhibited in the presence of suramin (3.2 Ϯ 0.9 A/cm 2 , n ϭ 4, P Ͻ 0.05), U73122 (Ϫ4.6 Ϯ 2.4 A/cm 2 , n ϭ 7, P Ͻ 0.01), or 2-APB (1.1 Ϯ 0.3 A/cm 2 , n ϭ 6, P Ͻ 0.05, Fig. 9D ). Taken together these findings are analogous to those in single cells and demonstrate that P2Y receptors contribute to the increase in ATP-stimulated transepithelial secretion through a CFTR-independent, but IP3-dependent, pathway.
DISCUSSION
Biliary epithelial cells play a prominent role in regulating the volume and composition of bile through secretion of fluid and electrolytes. Recently, ATP has emerged as an important autocrine/paracrine signaling molecule that is present in bile and integrates the diverse signals controlling responses. For example, increases in intracellular cAMP, cGMP, and Ca 2ϩ all increase ATP release, and elimination of extracellular ATP blocks the secretory response to cAMP (27) . In the present studies, the mechanisms responsible for the cellular response to ATP are examined. From combined pharmacological and functional approaches, the principal findings are that 1) ATP activates a 17-pS anion channel distinct from CFTR; 2) the mechanism involves receptor binding and PLC-and IP3-dependent release of calcium from intracellular stores; 3) pharmacological sensitivity of the response is most consistent with a dominant role for P2Y vs. P2X receptors localized to the apical domain of polarized monolayers; and 4) the resulting increase in transepithelial Cl Ϫ secretion is quantitatively important. In association with recent findings suggesting that the primary function of CFTR in biliary cells involves ATP release (27) , these findings suggest that the ATP release and P2Y receptor activation may represent a dominant pathway for regulation of biliary secretion.
Seven P2X receptors and eight P2Y receptors are currently recognized in mammals (1) . Freshly isolated rat cholangiocytes express P2Y1, P2Y2, P2Y4, P2Y6, and P2X4 receptors (11) . Mz-Cha-1 cells and NRC monolayers express a similar pattern of P2 receptors including P2Y2, P2X2, P2X4, P2X6 (10, 35, 39) . In these biliary preparations, P2X4 and P2Y2 are expressed in highest abundance and are present and functional on the apical membrane (10, 35) . P2Y2 and P2X4 can be distinguished by their distinct pharmacological profiles with a rank order of potency for P2Y2 of UTP ϭ ATP Ͼ 2meSATP Ͼ ADP and P2X4 of Bz-ATP Ͼ ATP Ͼ ␣␤meATP. Although there are no specific antagonists for the two P2 receptor subtypes, each demonstrates a different sensitivity to receptor blockers, with P2Y inhibited by suramin and RB-2 but rela- In the majority of secretory epithelium, agonist binding to P2Y initiates signaling through G q/11 to activate the PLC␤/IP3 pathway and release of intracellular Ca 2ϩ stores. Thus P2Y-linked ion channel activation potentially can occur through two pathways, including 1) direct interaction with activated G protein subunits or 2) an increase in [Ca 2ϩ ] i mediated by IP3 receptors. Direct G protein-gated anion channels have been identified in cholangiocytes and are negatively regulated by G i ␣-2 and/or G i ␣-3 and demonstrate voltage-dependent closure (26), properties quite dissimilar from the nucleotidestimulated channel described here. Additionally, the present studies demonstrate that ATP-activated Cl Ϫ current (I Cl.ATP ) requires intracellular Ca 2ϩ and intact PLC-IP3 signaling pathways. Moreover, intracellular dialysis with purified IP3 activates Cl Ϫ currents with identical properties to I Cl.ATP in the absence of a P2 agonist, providing further evidence of the involvement of the PLC-IP3 pathway in Cl Ϫ channel activation. Thus nucleotide binding to apical P2 receptors initiates a Ca 2ϩ signaling cascade, through PLC-␤ generation of IP3, resulting in Cl Ϫ channel activation in single-cell studies and transepithelial secretion in polarized preparations.
It should be noted that, in addition to the large increase in Cl Ϫ permeability measured during whole cell patch clamp studies, in ϳ65% of recordings ATP activated a small and transient current measured at 0 mV, consistent with the smallconductance Ca 2ϩ -activated K ϩ channel previously identified in biliary cells (14) . This outward K ϩ conductance may be necessary to maintain the electrical driving force for continued Cl Ϫ efflux and hence biliary secretion (37) . The role of these calcium-activated K ϩ channels, as well as other channels and transporters, mediating the secretory response to extracellular nucleotides deserves further investigation.
Further characterization of this integrated secretory response, utilizing polarized NRC monolayers, demonstrated that the ATP-stimulated increase in transepithelial secretion was two-to threefold greater than that induced by activation of CFTR by cAMP-IBMX. This has significant, physiological implications, because targeting the ATP-stimulated secretory pathway in cholangiocytes may potentially provide a therapeutic strategy for the treatment of cystic fibrosis-associated liver disease in which abnormal Cl Ϫ transport is felt to contribute to a decrease in bile flow, bile duct plugging, and progressive liver injury (17) . Strategies that target the P2-signaling pathway may increase fluid and electrolyte transport, augment bile flow, and therefore provide therapeutic benefit for cholestatic liver disorders such as cystic fibrosis associated with abnormal bile flow.
If these studies, performed in human and rat biliary epithelial models, translate to in vivo conditions, several points, as well as uncertainties, deserve highlighting. First, the molecular identity of the ATP-stimulated Cl Ϫ channel is unknown. The biophysical properties of I Cl.ATP with mild outward rectification, reversal at 0 mV, time-dependent inactivation at positive potentials, and dependence on intracellular calcium, are similar to the swelling-activated Cl Ϫ channel (16, 30, 31 ) and the flow-stimulated Cl Ϫ channel (44) previously described in biliary cells, which are both dependent on autocrine stimulation of membrane P2 receptors by extracellular ATP. I Cl.ATP , swellactivated I Cl Ϫ, and flow-activated I Cl Ϫ, all require intracellular Ca 2ϩ for activation and are similar to the Ca 2ϩ -activated Cl Ϫ channels previously described (34); however, the molecular identity of these as well as other epithelial Ca 2ϩ -activated Cl Ϫ channels remains unresolved. A Cl Ϫ channel activated by calcium/calmodulin protein kinase II (CaMKII) has previously been cloned from a cDNA library derived from bovine trachea and termed CaCC (or CLCA-1) (8, 21) . Although the cloned protein acts as a CaMKII-modulated Cl Ϫ channel when reconstituted in a lipid bilayer (29) , RT-PCR failed to detect transcripts for CaCC in biliary epithelia (unpublished observations), and it therefore appears unlikely that this gene product is related to Ca 2ϩ -activated Cl Ϫ channels in liver cells. Whole cell patch clamp studies were performed according to the protocol described in Fig. 1 . A-C: representative whole cell patch clamp recordings of ATP-stimulated (50 M) currents in the presence of U73343 (10 M) (A), U73122 (10 M) (B), or 2-APB (100 M) (C). D: cumulative data demonstrating effects of PLC or IP3 inhibition on ATPstimulated current density. *U73122 or 2-APB significantly (P Ͻ 0.001) inhibited ATP-stimulated currents. The inactive analog U73343 had no effect. Values represent maximum current density (pA/pF) measured at Ϫ80 mV (n ϭ 4 -9 each). Ϫ currents. Under whole cell patch clamp conditions (performed according to protocol described in Fig. 1 ), recombinant IP3 (20 M) was delivered to the cell interior by inclusion in the patch pipette. A: in control cells (without IP3), no spontaneous currents are noted (top tracing). Dialysis with IP3 resulted in spontaneous activation of membrane currents as IP3 diffused into the cell interior (bottom tracing). NPPB inhibited membrane currents. A voltage-step protocol (test potentials between Ϫ100 mV and ϩ100 mV in 20-mV increments) was obtained at times marked with ଙ during both basal and maximal current responses and shown below the trace, respectively. The I-V plot shown in B was generated from these protocols. B: I-V relationship of whole cell currents during basal (E) and intracellular dialysis with IP3 (F). C: cumulative data demonstrating maximum current density (pA/pF) measured at Ϫ80 mV under basal conditions, in response to extracellular ATP (50 M), or intracellular dialysis with IP3 (20 M). *Extracellular ATP (n ϭ 33) or intracellular IP3 (n ϭ 4) significantly increased current density (P Ͻ 0.001 and P Ͻ 0.005 vs. basal, respectively). Second, although the present studies demonstrate a predominant role of P2Y in mediating the secretory response to extracellular ATP, they do not exclude a possible contribution of P2X receptors. Previous studies of Mz-Cha-1 cells and NRC monolayers demonstrated that P2X4 stimulation results in a rapid inward current followed by a more sustained secretory response (10) , and Bz-ATP activates whole cell Cl Ϫ currents even in the absence of consistent changes in bulk cytosolic Ca 2ϩ concentration. In other secretory cells, homomeric P2X4 receptors function as Ca 2ϩ influx pathways to replenish intracellular Ca 2ϩ stores needed for sustained Cl Ϫ channel activation (45) . However, the permeability of Ca 2ϩ through the pore depends on the presence and concentration of other cations. For example, in homomeric receptors Na ϩ competes with Ca 2ϩ for permeation (5, 38) . Additionally, divalent cations, such as Mg 2ϩ , may either cause a fast channel block and/or decrease mean open times indicating an effect on channel gating of heterologously expressed P2X4 receptors (12, 28) . Thus the present studies utilizing an extracellular isotonic solution with Na ϩ and divalent cations, in concentrations similar to that of bile, may have underestimated a potential contribution of P2X4 under these experimental conditions. In fact, both P2X and P2Y probably contribute to calciumdependent signal transduction cascades to form an integrated and sustained secretory response in biliary epithelium. For example, upon agonist binding, P2Y2 receptor coupling to G proteins generates IP3, through PLC-␤, resulting in release of Ca 2ϩ from IP3 receptors, whereas simultaneous agonist binding to P2X4 receptors results in cation and Ca 2ϩ influx to replenish Ca 2ϩ stores necessary for continued secretion. As an additional source of intricacy, P2X and P2Y isoforms can each assemble into heteromultimers, adding an additional layer of complexity to the cellular responses to extracellular nucleotides. Third, the expression of distinct P2 receptors on the apical membrane may vary in response to changing physiological conditions. Cholangiocytes demonstrate a rapid rate of constitutive exocytosis capable of replacing 1.3% of the plasma membrane each minute and ϳ80% of the plasma membrane each hour (9) , and therefore the repertoire of P2 receptors available to bind nucleotides in bile may demonstrate minuteto-minute regulation. In fact, it has been shown that elements of the cholangiocyte cAMP-stimulated secretory apparatus, including CFTR, AE2, and AQP-1, may be packaged, transported, and inserted together during stimulated exocytosis (40) , presumably to achieve rapid and efficient secretory responses. If a similar paradigm exists for P2-mediated secretion, regulated exo-and endocytosis may rapidly modulate the expression of plasma membrane P2 receptors, channels, and/or other transporters, to achieve integrated responses during changing physiological conditions. Lastly, it is interesting to note that there is significant functional heterogeneity between small and large cholangiocytes in terms of secretory responses. In the rat, small cholangiocytes, from the "upstream" small intrahepatic bile ducts, do not express CFTR and have very little secretory response to cAMP, whereas large cholangiocytes, from "downstream" large ducts, express CFTR and respond to cAMP with large increases in fluid and electrolyte transport (2) . Although small cholangiocytes contribute only modestly to secretion, they nonetheless release hormones and growth factors capable of signaling to large cholangiocytes (2, 20, 41) . Thus a functional axis may exist along the bile duct to coordinate organ-level responses to physiological and pathological stimuli affecting the liver. Whether a P2-signaling axis exists along the bile duct, wherein ATP released from small cholangiocytes upstream may contribute importantly to local purinergic signaling, serve as a source for ATP in bile, and represent an important paracrine signal to the downstream P2 receptorexpressing large cholangiocytes, is unknown.
These considerations regarding multiple receptors in multiple configurations suggest that biliary purinergic signaling responses are likely to be shaped in response to changing physiological demands by changes in ATP release and even the types of receptors expressed. However, under the conditions of these studies, the P2Y pathway activating intracellular calcium release and ϳ17-pS anion channels predominates. Since there is increasing evidence that the cAMP-dependent secretory responses also depend on ATP release, this is likely to represent a final common pathway for the dominant conductance controlling transepithelial Cl Ϫ secretion. Accordingly, regula- tion of local P2 signaling pathways, through effects on ATP availability and/or delivery of receptor agonists, represents an attractive therapeutic target for treatment of cholestasis and other disorders associated with impaired bile formation.
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